Respective prevalence of the different carpentier classes of mitral regurgitation: A stepping stone for future therapeutic research and development

Journal of Cardiac Surgery

Volumn 26, Issue 4, 2011, Pages 385-392

  De Marchena, Eduardo ^a   Badiye, Amit ^a   Robalino, Giannina ^a   Junttila, Juhani ^a   Atapattu, Suresh ^a   Nakamura, Mamoo ^a   De Canniere, Didier ^b   Salerno, Tomas ^b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b JACKSON MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPHOSPHOLIPID SYNDROME; CARPENTIER FUNCTIONAL CLASSIFICATION; CARPENTIER TYPE I; CARPENTIER TYPE II; CARPENTIER TYPE IIIA; CARPENTIER TYPE IIIB; CONGESTIVE CARDIOMYOPATHY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ENDOCARDITIS; FUNCTIONAL ASSESSMENT; HEART LEFT VENTRICLE FAILURE; HUMAN; ISCHEMIC CARDIOMYOPATHY; MEDLINE; MITRAL VALVE PROLAPSE; MITRAL VALVE REGURGITATION; POPULATION RESEARCH; PREVALENCE; RARE DISEASE; REVIEW; RHEUMATIC HEART DISEASE; SYSTEMATIC REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; TROPICAL DISEASE; UNITED STATES;

HUMANS; MITRAL VALVE INSUFFICIENCY; PREVALENCE; UNITED STATES;

EID: 79961053097     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/j.1540-8191.2011.01274.x     Document Type: Review

References (45)

1. Nkomo VT, Gardin JM, Skelton TN, et al,: Burden of valvular heart diseases: A population-based study. Lancet 2006; 368: 1005-1011. (Pubitemid 44353666)
2. Tribouilloy C, Enriquez-Sarano M, Schaff H, et al,: Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: Rationale for optimizing surgical indications. Circulation 1999; 99: 400-405. (Pubitemid 29051266)
3. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al,: Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 2005; 352: 875-883. (Pubitemid 40300296)
4. Ling LH, Enriquez-Sarano M, Seward JB, et al,: Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med 1996; 335: 1417-1423. (Pubitemid 26382502)
5. Carpentier A, Chauvaud S, Fabiani JN, et al,: Reconstructive surgery of mitral valve incompetence: Ten-year appraisal. J Thorac Cardiovasc Surg 1980; 79: 338-348. (Pubitemid 10131047)
6. U.S. Census Bureau: "2008 National Population Projections," released August 2008, Available at:. Accessed on September 15, 2009.
7. Carpentier A,: Cardiac valve surgery: 'The French correction'. J Thorac Cardiovasc Surg 1983; 86: 323-337. (Pubitemid 13002097)
8. Schwammenthal E, Nakatani S, He S, et al,: Mechanism of mitral regurgitation in hypertrophic cardiomyopathy: Mismatch of posterior to anterior leaflet length and mobility. Circulation 1998; 98: 856-865. (Pubitemid 28397435)
9. Kaul S, Pearlman JD, Touchstone DA, et al,: Prevalence and mechanisms of mitral regurgitation in the absence of intrinsic abnormalities of the mitral leaflets. Am Heart J 1989; 118: 963-972. (Pubitemid 19275861)
10. Sareyyupoglu B, Schaff HV, Suri RM, et al,: Safety and durability of mitral valve repair for anterior leaflet perforation. J Thorac Cardiovasc Surg 2010; 139: 1488-1493.
11. Glower DD, Bashore TM, Harrison JK, et al,: Pure annular dilation as a cause of mitral regurgitation: A clinically distinct entity of female heart disease. J Heart Valve Dis 2009; 18: 284-288.
12. Heart Disease and Stroke Statistics-2009 Update. Available at:. Accessed on September 1, 2009.
13. Avierinos JF, Gersh BJ, Melton LJ 3rd, et al,: Natural history of asymptomatic mitral valve prolapse in the community. Circulation 2002; 106: 1355-1361. (Pubitemid 35013038)
14. Singh RG, Cappucci R, Kramer-Fox R, et al,: Severe mitral regurgitation due to mitral valve prolapse: Risk factors for development, progression, and need for mitral valve surgery. Am J Cardiol 2000; 85: 193-198. (Pubitemid 30026101)
15. " Marfan Syndrome Facts.": Jun 2006. National Marfan Foundation. Available at:. Accessed on 17 April, 2009.
16. Bhudia SK, Throughton R, Lam BK, et al,: Mitral valve surgery in the adult Marfan Syndrome patient. Ann Thorac Surg 2006; 81: 843-848. (Pubitemid 43247648)
17. Murdoch DR, Corey GR, Hoen B, et al,: Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: The International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009; 169: 463-473.
18. Rahimtoola SH, Enquez-Sarano M, et al,: Mitral valve disease. In:, Valentin F., et al. (eds.) Hurst's The Heart. 10th ed. McGraw-Hill, New York, 2001.
19. "Ehlers-Danlos Syndrome." May 2006. Genetics Home Reference. Available at:. Accessed on 17 April, 2009.
20. Simmers TA, Meijburg HW, de la Rivière AB,: Traumatic papillary muscle rupture. Ann Thorac Surg 2001; 72: 257-259. (Pubitemid 32643051)
21. Russo A, Suri RM, Grigioni F, et al,: Clinical outcome after surgical correction of mitral regurgitation due to papillary muscle rupture. Circulation 2008; 118: 1528-1534.
22. Anderson Y, Wilson N, Nicholson R, et al,: Fulminant mitral regurgitation due to ruptured chordae tendinae in acute rheumatic fever. J Paediatr Child Health 2008; 44: 134-137. (Pubitemid 351326863)
23. Roldan CA, Shively BK, Lau CC, et al,: Systemic lupus erythematosus valve disease by transesophageal echocardiography and the role of antiphospholipid antibodies. J Am Coll Cardiol 1992; 20: 1127-1134.
24. Antiphospholipid Antibody Syndrome." 15 Oct 2006. APS Foundation of America, Inc. Available at:. Accessed on April 17, 2009.
25. Schaffer WL, Galloway JM, Roman MJ, et al,: Prevalence and correlates of rheumatic heart disease in American Indians (the Strong Heart Study). Am J Cardiol 2003; 91: 1379-1382. (Pubitemid 36593493)
26. Kumar AS, Talwar S, Saxena A, et al,: Results of mitral valve repair in rheumatic mitral regurgitation. Interact Cardiovasc Thorac Surg 2006; 5: 356-361. (Pubitemid 44166435)
27. Murphy JG, Lloyd MA,: Carcinoid and drug-related heart disease. In, Murphy JG, Lloyd MA, eds. Mayo Clinic cardiology-Concise Textbook. Mayo Clinic Scientific Press, 3rd edn. 2006, pp. 560-561.
28. Rigante D, Segni G,: Cardiac structural involvement in mucopolysaccharidoses. Cardiology 2002; 98: 18-20. (Pubitemid 35375648)
29. Yacoub S, Kotit S, Mocumbi AO, et al,: Neglected diseases in cardiology: A call for urgent action. Nat Clin Pract Cardiovasc Med 2008; 5: 176-177. (Pubitemid 351472157)
30. Trichon BH, Felker GM, Shaw LK, et al,: Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 2003; 91: 538-543. (Pubitemid 36263251)
31. Impact of Medical and Surgical Therapy on Functional Mitral Regurgitation. 11 December 2007. U.S. National Institutes of Health. Available at:. Accessed on April 22, 2009.
32. Lamas GA, Mitchell GF, Flaker GC, et al,: Clinical significance of mitral regurgitation after acute myocardial infarction. Survival and Ventricular Enlargement Investigators. Circulation 1997; 96: 827-833. (Pubitemid 27329616)
33. Maron BJ, Towbin JA, Thiene G, et al,: Contemporary definitions and classification of the cardiomyopathies: An american heart association scientific statement from the council on clinical cardiology, heart failure and transplantation committee; quality of care and outcomes research and functional genomics and translational biology interdisciplinary working groups; and council on epidemiology and prevention. Circulation 2006; 113: 1807-1816. (Pubitemid 43958474)
34. Ngaage DL, Schaff HV,: Mitral valve surgery in non-ischemic cardiomyopathy. J Cardiovasc Surg (Torino) 2004; 45: 477-486. (Pubitemid 40074195)
35. Hanna SR, Chung ES, Aurigemma GP, et al,: Worsening of mitral regurgitation secondary to ventricular pacing. J Heart Valve Dis 2000; 9: 273-275. (Pubitemid 30187011)
36. Kihara T, Gillinov AM, Takasaki K, et al,: Regurgitation associated with mitral annular dilation in patients with lone atrial fibrillation: An echocardiographic study. Echocardiography 2009; 26: 885-889.
37. Kaple RK, Murphy RT, DiPaola LM, et al,: Mitral valve abnormalities in hypertrophic cardiomyopathy: Echocardiographic features and surgical outcomes. Ann Thorac Surg 2008; 85: 1527-1535, 1535.e1-e2.
38. Maron BJ, Gardin JM, Flack JM, et al,: Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary artery risk development in (Young) adults. Circulation 1995; 92: 785-789.
39. Savage D, Garnison R, Castelli W, et al,: Prevalence of submitral calcium and its correlation in the general population-base sample (the Framingham study). Am J Cardiol 1983; 51: 1375-1378. (Pubitemid 13133082)
40. Umana E, Ahmed W, Alpert MA,: Valvular and perivalvular abnormalities in end-stage renal disease. Am J Med Sci 2003; 325 (4): 237-242. (Pubitemid 36437996)
41. Hayek E, Gring CN, Griffin BP,: Mitral valve prolapse. Lancet 2005; 365: 507-518. (Pubitemid 40215734)
42. Enriquez-Sarano M, Akins CW, Vahanian A,: Mitral regurgitation. Lancet 2009; 373: 1382-1394.
43. Vahanian A, Baumgartner H, Bax J, et al,: Guidelines on the management of valvular heart disease: The task force on the management of valvular heart disease of the European Society of Cardiology. Eur Heart J 2007; 28: 230-268. (Pubitemid 46276943)
44. Bach DS,: Functional mitral regurgitation and transcatheter mitral annuloplasty: The carillon mitral annuloplasty device european union study in perspective. Circulation 2009; 120: 272-274.
45. Coats AJ,: Ethical authorship and publishing. Int J Cardiol 2009; 131: 149-150.